Adrenal

Watch this webinar recording and complete the CME/CPD activity to explore the intricate world of endocrine and renal causes behind resistant hypertension. Discover the critical path to diagnosis and effective treatment for this serious, and often overlooked condition.

Pituitary surgery is the first-line treatment of Cushing’s disease. However, despite being in remission for months or years, approximately 20-25% may experience recurrence of the disease. The post-operative prognostic criteria for predicting prolonged remission are debatable. Furthermore, the diagnosis of Cushing's disease at an early stage of recurrence presents particular difficulties. Several therapeutic options are possible in patients not cured by surgery.  Severe Cushing’s syndrome...

Primary aldosteronism is a highly prevalent and severely under-diagnosed syndrome that contributes to cardiovascular and kidney disease that can be mitigated with targeted therapies. This activity reviews major updates in our understanding of this syndrome, its diagnosis, and optimal treatment.

The content of this course was developed by Dr Stefanie Hahner, Dr Louis Ian Ross, Dr Richard Ross, and Dr Antoine Tabarin.